Company / Current Liabilities
Nuo Therapeutics, Inc. Current Liabilities History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$936.8K
FY2017
5-year range
$936.8K / $42.2M
FY2013-FY2017
Trend
-35.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 7 years, ranging from $936,837 in FY2017 to $42M in FY2015.
Based on SEC 10-K filings.
$936,837 in FY2017 with a 5-year CAGR of -19.7%.
Improved from $42M to $936,837 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -52.1%
- 5-Year CAGR
- -19.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -19.7%, indicating a declining trend.
- In FY2017, current liabilities decreased 35.3% year-over-year.
- Peak current liabilities was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $936.8K | -35.3% |
| FY2016 | $1.4M | -96.6% |
| FY2015 | $42.2M | +396.4% |
| FY2014 | $8.5M | -19.5% |
| FY2013 | $10.6M | +275.5% |
| FY2012 | $2.8M | -10.4% |
| FY2011 | $3.1M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026